Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovex International (INVX) EBITDA (2016 - 2025)

Innovex International's EBITDA history spans 17 years, with the latest figure at $14.3 million for Q4 2025.

  • For Q4 2025, EBITDA fell 32.69% year-over-year to $14.3 million; the TTM value through Dec 2025 reached $96.2 million, down 26.76%, while the annual FY2025 figure was $96.2 million, 25.6% down from the prior year.
  • EBITDA reached $14.3 million in Q4 2025 per INVX's latest filing, down from $40.5 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $85.0 million in Q3 2024 to a low of -$72.2 million in Q4 2021.
  • Average EBITDA over 5 years is $10.8 million, with a median of $13.3 million recorded in 2022.
  • Peak YoY movement for EBITDA: tumbled 520.51% in 2021, then skyrocketed 483.65% in 2024.
  • A 5-year view of EBITDA shows it stood at -$72.2 million in 2021, then soared by 201.0% to $72.9 million in 2022, then plummeted by 76.67% to $17.0 million in 2023, then rose by 24.6% to $21.2 million in 2024, then plummeted by 32.69% to $14.3 million in 2025.
  • Per Business Quant, the three most recent readings for INVX's EBITDA are $14.3 million (Q4 2025), $40.5 million (Q3 2025), and $22.1 million (Q2 2025).